CelLBxHealth has secured a collaboration with AdventHealth to use its Parsortix platform in two US clinical cancer studies, ACTION and SUNRISE. These trials will analyze circulating tumor cells (CTCs) from blood samples of patients with colon, gastrointestinal, and lung cancers to monitor tumor response to treatment non-invasively. The collaboration aims to improve cancer care accessibility by enabling advanced monitoring through simple blood draws, potentially reducing the need for invasive biopsies. AdventHealth's extensive US network offers CelLBxHealth a strong platform to validate and expand Parsortix's clinical use.
Sodexo has secured a major global contract to provide catering services across more than 130 Meta sites in over 30 countries. This large-scale partnership includes diverse locations such as headquarters, campuses, data centers, and conference centers...
DMG Blockchain Solutions announced two strategic investments: one in MeetAmi Innovations, a Canadian fintech offering digital asset wealth management platforms, and another in Atomic47 Labs, an AI company focused on secure, sovereign AI infrastructur...
Gnosis (GNO) surged 13% in 24 hours, closing in on overtaking BONK by market capitalization to reach the 100th largest token spot. GNO's market cap stands at $303.88 million versus BONK's $330.07 million, requiring a price rise to about $125.48 for t...
Broadridge's Tokenization Pulse Survey shows 84% of firms view tokenization as strategically important, with 68% expecting it to reshape markets within 3-5 years. Most firms plan to integrate tokenization into existing infrastructure rather than buil...
Standard Chartered has partnered with Broadcom to modernize its global banking infrastructure by adopting a secure, resilient private cloud using VMware Cloud Foundation. This upgrade supports critical banking services across 54 markets with enhanced...
